Skip to main content
. Author manuscript; available in PMC: 2017 Feb 24.
Published in final edited form as: Oncogene. 2016 Aug 15;36(8):1157–1166. doi: 10.1038/onc.2016.286

Figure 4. Twist1 inhibits AP1-mediated activation of the Foxa1 promoter by inhibiting AP1 recruitment.

Figure 4

A. The two conserved AP1 sites in both human and mouse Foxa1 promoter regions. B. Luciferase activity of MCF7 cells transfected with Foxa1-Luc plasmid with the empty vector (−) or c-Jun and c-Fos expression vectors. C. Q-PCR and Western blot assays showing Foxa1 mRNA and protein changes upon c-fos knockdown in MCF7 cells. D. Luciferase assay of MCF7 cells co-transfected with the indicated luciferase reporter and the empty vector (−) or c-Jun and c-Fos expression vectors. E. ChIP assays performed with MCF7Ctrl and MCF7Twist1 cells and non-immune IgG (negative control) or c-Fos antibody as indicated. The DNA fragment between the two arrowheads in Panel A was amplified by PCR from the immunoprecipitated DNA. Amplification of the known AP1-binding region by PCR in the CSF1 promoter served as a positive control. F. Luciferase assay of MCF7 cells co-transfected with the indicated luciferase reporter and the empty vector (Ctrl) or Twist1 expression plasmid. Experiments were repeated 3 times and the representative data with 3 technical replicates are presented as Mean ± SEM. * in Panels B–F, P<0.05 by Student's t test.